KEGG_PATHWAYS_IN_CANCER |
328 |
Pathways in cancer |
25 |
0.0762 |
5.43E−18 |
7.22E−15 |
PID_P53_DOWNSTREAM_PATHWAY |
137 |
Direct p53 effectors |
13 |
0.0949 |
3.58E−11 |
2.18E−08 |
KEGG_TYPE_II_DIABETES_MELLITUS |
47 |
Type II diabetes mellitus |
9 |
0.1915 |
6.19E−11 |
2.18E−08 |
KEGG_PROSTATE_CANCER |
89 |
Prostate cancer |
11 |
0.1236 |
6.55E−11 |
2.18E−08 |
REACTOME_DEVELOPMENTAL_BIOLOGY |
396 |
Genes involved in Developmental Biology |
19 |
0.048 |
1.82E−10 |
4.84E−08 |
REACTOME_SIGNALLING_BY_NGF |
217 |
Genes involved in Signalling by NGF |
14 |
0.0645 |
1.08E−09 |
2.39E−07 |
KEGG_THYROID_CANCER |
29 |
Thyroid cancer |
7 |
0.2414 |
1.52E−09 |
2.84E−07 |
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES |
67 |
Genes related to PIP3 signaling in cardiac myocytes |
9 |
0.1343 |
1.71E−09 |
2.84E−07 |
KEGG_FOCAL_ADHESION |
201 |
Focal adhesion |
13 |
0.0647 |
4.15E−09 |
6.13E−07 |
REACTOME_IMMUNE_SYSTEM |
933 |
Genes involved in Immune System |
26 |
0.0279 |
9.84E−09 |
1.31E−06 |
KEGG_COLORECTAL_CANCER |
62 |
Colorectal cancer |
8 |
0.129 |
1.93E−08 |
2.33E−06 |
REACTOME_ADAPTIVE_IMMUNE_SYSTEM |
539 |
Genes involved in Adaptive Immune System |
19 |
0.0353 |
2.77E−08 |
3.07E−06 |
KEGG_NOTCH_SIGNALING_PATHWAY |
47 |
Notch signaling pathway |
7 |
0.1489 |
5.45E−08 |
5.58E−06 |
PID_HES_HEY_PATHWAY |
48 |
Notch−mediated HES/HEY network |
7 |
0.1458 |
6.34E−08 |
6.02E−06 |
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES |
51 |
Genes related to the insulin receptor pathway |
7 |
0.1373 |
9.79E−08 |
8.67E−06 |
KEGG_ENDOMETRIAL_CANCER |
52 |
Endometrial cancer |
7 |
0.1346 |
1.12E−07 |
9.34E−06 |
REACTOME_SIGNALING_BY_FGFR |
112 |
Genes involved in Signaling by FGFR |
9 |
0.0804 |
1.64E−07 |
1.12E−05 |
PID_FGF_PATHWAY |
55 |
FGF signaling pathway |
7 |
0.1273 |
1.67E−07 |
1.12E−05 |
BIOCARTA_ERK5_PATHWAY |
18 |
Role of Erk5 in Neuronal Survival |
5 |
0.2778 |
1.68E−07 |
1.12E−05 |
BIOCARTA_PTEN_PATHWAY |
18 |
PTEN dependent cell cycle arrest and apoptosis |
5 |
0.2778 |
1.68E−07 |
1.12E−05 |